106 related articles for article (PubMed ID: 19819285)
1. Attenuation of cytogenetic effects by erythropoietin in human lymphocytes in vitro and P388 ascites tumor cells in vivo treated with irinotecan (CPT-11).
Digkas E; Kareli D; Chrisafi S; Passadaki T; Mantadakis E; Hatzimichail A; Vargemezis V; Lialiaris T
Food Chem Toxicol; 2010 Jan; 48(1):242-9. PubMed ID: 19819285
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo cytogenetic effects of recombinant human erythropoietin on the frequency of sister chromatid exchanges alone or in combination with mitomycin C.
Digkas EN; Chrisafi S; Passadaki T; Tsalkidis A; Hatzimichail A; Vargemezis V; Lialiaris TS
Chemotherapy; 2010; 56(3):239-47. PubMed ID: 20551641
[TBL] [Abstract][Full Text] [Related]
4. Cytoprotective activity of amifostine on cultured human lymphocytes exposed to irinotecan.
Lialiaris TS; Kotsiou E; Pouliliou S; Kareli D; Makrinou H; Kouskoukis A; Papachristou F; Koukourakis M
Food Chem Toxicol; 2009 Oct; 47(10):2445-9. PubMed ID: 19577607
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivo.
Tsuruo T; Matsuzaki T; Matsushita M; Saito H; Yokokura T
Cancer Chemother Pharmacol; 1988; 21(1):71-4. PubMed ID: 3342468
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cytogenetic and antitumor effects by 9-nitrocamptothecin and antineoplastics.
Karaberis E; Mourelatos D
Teratog Carcinog Mutagen; 2000; 20(3):141-6. PubMed ID: 10820424
[TBL] [Abstract][Full Text] [Related]
7. Effect of maternal smoking during pregnancy on fetus: a cytogenetic perspective.
Kareli D; Pouliliou S; Nikas I; Psillaki A; Karelis A; Nikolettos N; Galazios G; Liberis V; Lialiaris T
J Matern Fetal Neonatal Med; 2014 Jan; 27(2):127-31. PubMed ID: 23682763
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic effects of CPT-11 and its active metabolite, SN-38 on human lymphocytes.
Kojima A; Shinkai T; Saijo N
Jpn J Clin Oncol; 1993 Apr; 23(2):116-22. PubMed ID: 8515576
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotective and genotoxic effects of vitamins K1 and B1 on irinotecan in vitro.
Giarma E; Mpampali Z; Lialiaris T; Mourelatos D
Mutat Res Genet Toxicol Environ Mutagen; 2019 Jan; 837():60-64. PubMed ID: 30595211
[TBL] [Abstract][Full Text] [Related]
10. The genotoxic effects of anti-cancer drug gossypol on human lymphocytes and its mitigation by melatonin.
Rao MV; Narechania MB
Drug Chem Toxicol; 2016 Oct; 39(4):357-61. PubMed ID: 27071859
[TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of amiodarone for the treatment of murine leukemia P388. In vivo and in vitro investigation.
Papageorgiou AD; Dalezis P; Mourelatos C; Lioutas K; Sahpazidou D; Geromichalou E; Geromichalos G; Lialiaris T; Athanasiadou P; Athanasiadis P
J BUON; 2010; 15(3):568-71. PubMed ID: 20941829
[TBL] [Abstract][Full Text] [Related]
12. Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.
Lialiaris TS; Papachristou F; Mourelatos C; Simopoulou M
Anticancer Drugs; 2009 Sep; 20(8):746-51. PubMed ID: 19584706
[TBL] [Abstract][Full Text] [Related]
13. A new approach for evaluating in vivo anti-leukemic activity using the SCE assay. An application on three newly synthesised anti-tumour steroidal esters.
Karayianni V; Mioglou E; Iakovidou Z; Mourelatos D; Fousteris M; Koutsourea A; Arsenou E; Nikolaropoulos S
Mutat Res; 2003 Feb; 535(1):79-86. PubMed ID: 12547285
[TBL] [Abstract][Full Text] [Related]
14. Irinotecan toxicity to human blood cells in vitro: relationship between various biomarkers.
Kopjar N; Zeljezić D; Vrdoljak AL; Radić B; Ramić S; Milić M; Gamulin M; Pavlica V; Fucić A
Basic Clin Pharmacol Toxicol; 2007 Jun; 100(6):403-13. PubMed ID: 17516995
[TBL] [Abstract][Full Text] [Related]
15. Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content.
Eng WK; McCabe FL; Tan KB; Mattern MR; Hofmann GA; Woessner RD; Hertzberg RP; Johnson RK
Mol Pharmacol; 1990 Oct; 38(4):471-80. PubMed ID: 2172765
[TBL] [Abstract][Full Text] [Related]
16. Action of (S)-10-hydroxycamptothecin on P388 leukemia and distribution of the drug in mice.
Creasey WA; Richards M; Gil D; Tsou KC
Cancer Treat Rep; 1983 Feb; 67(2):179-82. PubMed ID: 6825126
[TBL] [Abstract][Full Text] [Related]
17. Antitumor and cytogenetic effects of esteric (ASE) and amidic (ASA) steroidal derivative of p-bis (2-chloroethyl) amino phenylacetic acid (CAPA). A comparative study.
Nikolaropoulos SS; Arsenou ES; Papageorgiou A; Mourelatos D
Anticancer Res; 1997; 17(6D):4525-9. PubMed ID: 9494562
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the cytogenetic and antineoplasmatic effects induced by carboplatin in combination with niacin in human lymphocytes in vitro and in Ehrlich ascites tumor cells in vivo.
Mylonaki-Charalambours E; Mourelatos D; Kotsis A
Chemotherapy; 1998; 44(2):121-8. PubMed ID: 9551243
[TBL] [Abstract][Full Text] [Related]
19. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.
Kawato Y; Aonuma M; Hirota Y; Kuga H; Sato K
Cancer Res; 1991 Aug; 51(16):4187-91. PubMed ID: 1651156
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity and sister chromatid exchanges induced in vitro by six anticancer drugs developed in the People's Republic of China.
Huang CC; Han CS; Yue XF; Shen CM; Wang SW; Wu FG; Xu B
J Natl Cancer Inst; 1983 Oct; 71(4):841-7. PubMed ID: 6413744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
